Covered Stents Versus Bare-Metal Stents
Primary Purpose
Gastrointestinal Vascular Conditions, Arteriosclerosis, Lifestyle-related Condition
Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Covered stent (Atrium Type V12)
Bare stent (Brand Cordis Type Palmaz Blue)
Sponsored by
About this trial
This is an interventional treatment trial for Gastrointestinal Vascular Conditions focused on measuring endovascular treatment, arterial occlusive disease, bare metal stent, polytetrafluoroethylene covered stent
Eligibility Criteria
Inclusion Criteria:
- Patients with consensus diagnostic of CGI based on a clinical meeting with a gastroenterologist, a vascular surgeon and an interventional radiologist.
- Diagnostic consensus of CGI is based on.
- Presence of postprandial pain
- Unexplained weight loss (>5% of normal body weight).
- Significant stenosis of >50% of at least one of the gastrointestinal arteries on a recent CTA (Computer Tomographic Angiography) not older than one year, with maximum slice thickness 1 mm and enhancement in aorta of 300HU (Hounsfields Units)
- Mucosal ischemia detected by VLS (Visible Light Spectroscopy) or tonometry
- Patients over the age of 18 years.
- Patients who gave informed consent.
- Patients have sustained atherosclerosis.
Exclusion Criteria:
- Patients who don't give informed consent.
- Age < 18 years
- No stenosis detected during arteriography.
- Renal insufficiency (GFR below 30 ml/min or GFR below 60 ml/min when comorbidities relevant to kidney function present).
- Previous stent placement in the to be treated gastrointestinal artery.
- Pregnancy
- Celiac artery compression syndrome.
- Vasculitis
Sites / Locations
- ErasmusMC
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
bare stent inserted
Covered stent inserted
Arm Description
Standard bare stent will be placed
Covered stent will be placed
Outcomes
Primary Outcome Measures
The difference of primary and secondary patency rates of covered stents versus bare-metal stents to treat atherosclerotic CGI disease.
Secondary Outcome Measures
The freedom from restenosis after 6-, 12- and 24- months after stent implantation
Restenosis is defined as >50% intra-stent stenosis regardless of whether the patient has clinical symptoms
The freedom from symptom recurrence after 6-, 12- and 24- months after stent implantation
Symptom recurrence is defined as occurrence of clinical symptoms typical for CGI regardless of stent patency
The freedom from reintervention after 6-, 12- and 24- months after stent implantation
Re-intervention is defined as intervention due to symptom occurrence in the presence of >50% intra -stenosis, either a reimplantation of stent or a surgical procedure.
The clinical outcome in terms of quality of life and therapeutic and total costs after 6-, 12- and 24- months after stent implantation
The clinical outcome in terms therapeutic and total costs after 6-, 12- and 24- months after stent implantation
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02428582
Brief Title
Covered Stents Versus Bare-Metal Stents
Official Title
Covered Stents Versus Bare-Metal Stents in Chronic Atherosclerotic Gastrointestinal Ischemia
Study Type
Interventional
2. Study Status
Record Verification Date
March 2021
Overall Recruitment Status
Unknown status
Study Start Date
May 2016 (undefined)
Primary Completion Date
November 2021 (Anticipated)
Study Completion Date
November 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Erasmus Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To compare the outcome of revascularisation the gastrointestinal arteries using covered stents compared to bare-metal stents in patients with CGI.
Detailed Description
Symptomatic chronic atherosclerotic gastrointestinal ischemia (CGI) is an uncommon, potentially underdiagnosed condition caused by fixed stenosis or occlusion of in most conditions at least one of the three gastrointestinal arteries. Atherosclerosis is a predisposing factor for CGI. Clinical symptoms can vary widely. Typical symptoms are postprandial abdominal pain, unintended weight loss and food avoidance. But atypical abdominal pain such as exercise related pain, diarrhoea and nausea can also indicate CGI. The use of endovascular techniques for revascularization of chronic stenosis and occlusions of the gastrointestinal arteries has rapidly increased and endovascular therapy with stenting has become the most common method chosen for revascularization, having replaced open surgery with its associated morbidity and mortality. Nowadays standard care in significant chronic gastrointestinal ischemia is the use of bare metal stents although the patency of these stents is not very high. According retrospective data the patency of covered stents is significantly higher compared to bare metal stents. One likely explanation for these lower restenosis and re-intervention rates observed with covered stents is the established barrier to tissue ingrowth. Only recent retrospective data about this topic is available but the expectancy in this prospective study is that the patency of covered stents is indeed higher compared to metal stents.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastrointestinal Vascular Conditions, Arteriosclerosis, Lifestyle-related Condition, Stenosis, Vascular Insufficiency, Necrosis
Keywords
endovascular treatment, arterial occlusive disease, bare metal stent, polytetrafluoroethylene covered stent
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
84 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
bare stent inserted
Arm Type
Active Comparator
Arm Description
Standard bare stent will be placed
Arm Title
Covered stent inserted
Arm Type
Experimental
Arm Description
Covered stent will be placed
Intervention Type
Device
Intervention Name(s)
Covered stent (Atrium Type V12)
Intervention Description
An endovascular treatment that consists of inserting a covered stent into the stenosed vessels.
Intervention Type
Device
Intervention Name(s)
Bare stent (Brand Cordis Type Palmaz Blue)
Other Intervention Name(s)
Brand Cordis Type Palmaz Blue
Intervention Description
An endovascular treatment that consists of inserting a stent into the stenosed vessels.
Primary Outcome Measure Information:
Title
The difference of primary and secondary patency rates of covered stents versus bare-metal stents to treat atherosclerotic CGI disease.
Time Frame
12 to 24 months
Secondary Outcome Measure Information:
Title
The freedom from restenosis after 6-, 12- and 24- months after stent implantation
Description
Restenosis is defined as >50% intra-stent stenosis regardless of whether the patient has clinical symptoms
Time Frame
6 to 24 month
Title
The freedom from symptom recurrence after 6-, 12- and 24- months after stent implantation
Description
Symptom recurrence is defined as occurrence of clinical symptoms typical for CGI regardless of stent patency
Time Frame
6 to 24 month
Title
The freedom from reintervention after 6-, 12- and 24- months after stent implantation
Description
Re-intervention is defined as intervention due to symptom occurrence in the presence of >50% intra -stenosis, either a reimplantation of stent or a surgical procedure.
Time Frame
6 to 24 month
Title
The clinical outcome in terms of quality of life and therapeutic and total costs after 6-, 12- and 24- months after stent implantation
Time Frame
6 to 24 month
Title
The clinical outcome in terms therapeutic and total costs after 6-, 12- and 24- months after stent implantation
Time Frame
6 to 24 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with consensus diagnostic of CGI based on a clinical meeting with a gastroenterologist, a vascular surgeon and an interventional radiologist.
Diagnostic consensus of CGI is based on.
Presence of postprandial pain
Unexplained weight loss (>5% of normal body weight).
Significant stenosis of >50% of at least one of the gastrointestinal arteries on a recent CTA (Computer Tomographic Angiography) not older than one year, with maximum slice thickness 1 mm and enhancement in aorta of 300HU (Hounsfields Units)
Mucosal ischemia detected by VLS (Visible Light Spectroscopy) or tonometry
Patients over the age of 18 years.
Patients who gave informed consent.
Patients have sustained atherosclerosis.
Exclusion Criteria:
Patients who don't give informed consent.
Age < 18 years
No stenosis detected during arteriography.
Renal insufficiency (GFR below 30 ml/min or GFR below 60 ml/min when comorbidities relevant to kidney function present).
Previous stent placement in the to be treated gastrointestinal artery.
Pregnancy
Celiac artery compression syndrome.
Vasculitis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Adriaan Moelker, dr
Organizational Affiliation
Erasmus Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
ErasmusMC
City
Rotterdam
State/Province
Zuid Holland
ZIP/Postal Code
3015CE
Country
Netherlands
12. IPD Sharing Statement
Citations:
PubMed Identifier
31429792
Citation
van Dijk LJD, Harki J, van Noord D, Verhagen HJM, Kolkman JJ, Geelkerken RH, Bruno MJ, Moelker A; Dutch Mesenteric Ischemia Study group (DMIS). Covered stents versus Bare-metal stents in chronic atherosclerotic Gastrointestinal Ischemia (CoBaGI): study protocol for a randomized controlled trial. Trials. 2019 Aug 20;20(1):519. doi: 10.1186/s13063-019-3609-8.
Results Reference
derived
Learn more about this trial
Covered Stents Versus Bare-Metal Stents
We'll reach out to this number within 24 hrs